Is Anebulo Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: ANEB) stock is to Buy ANEB stock.
Out of 1 analyst, 0 (0%) are recommending ANEB as a Strong Buy, 1 (100%) are recommending ANEB as a Buy, 0 (0%) are recommending ANEB as a Hold, 0 (0%) are recommending ANEB as a Sell, and 0 (0%) are recommending ANEB as a Strong Sell.
What is ANEB's forecast return on equity (ROE) for 2025-2025?
(NASDAQ: ANEB) forecast ROE is -142.78%, which is considered weak.
What is ANEB's Price Target?
According to 1 Wall Street analyst that have issued a 1 year ANEB price target, the average ANEB price target is $8.00, with the highest ANEB stock price forecast at $8.00 and the lowest ANEB stock price forecast at $8.00.
The Wall Street analyst predicted that Anebulo Pharmaceuticals's share price could reach $8.00 by Nov 19, 2025. The average Anebulo Pharmaceuticals stock price prediction forecasts a potential upside of 742.11% from the current ANEB share price of $0.95.
What is ANEB's forecast return on assets (ROA) for 2025-2025?
(NASDAQ: ANEB) forecast ROA is -134.86%, which is lower than the forecast US Biotechnology industry average of 103.31%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.